Hi Everyone,
I just read a couple of good device articles on the NEJM that were recommended to me. I have posted these on the HCC facebook page as well. The second one is a bit more of a story, whereas the first is almost a position paper.
Perspective piece on the importance of postmarket surveillance in Medical Devices and where the author sees the gaps. http://www.nejm.org/doi/full/10.1056/NEJMp1114865?query=TOC
Also fresh from the NEJM, a piece on the recent Class 1 recall of Riata, the implantable cardioverter–defibrillator (ICD) leads from St. Jude Medical. 79,000 patients in the US! http://www.nejm.org/doi/full/10.1056/NEJMp1114695?query=TOC
Take care,
TM
| Tom Masterson HARVARD | BUSINESS | SCHOOL mobile: 617.699.3149 | tmast...@mba2013.hbs.edu |